2024

• Caruana, M., Grogan, P., Smith, D., O'Connell, D., Canfell, K., Gulati, R., Etzioni, R., Barratt, A., Armstrong, B., Chiam, K., Nair-Shalliker, V., Luo, Q., Bang, S. (2024). Benefits and harms of prostate specific antigen testing according to Australian guidelines. International Journal of Cancer, 154(4), 648-658. [More Information]
• Gallagher, B., Chiam, K., Bang, S., Patel, M., Kench, J., Edwards, S., Nair-Shalliker, V., Smith, D. (2024). Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study. Pathology, 56(1), 39-46. [More Information]
• Mizrahi, D., Lai, J., Wareing, H., Ren, Y., Li, T., Swain, C., Smith, D., Adams, D., Martiniuk, A., David, M. (2024). Effect of exercise interventions on hospital length of stay and admissions during cancer treatment: a systematic review and meta-analysis. British Journal of Sports Medicine, 58(2), 97-109. [More Information]
• Green, A., Newton, R., Smith, D., Tuffaha, H., Galvão, D., Heathcote, P., Patel, M., Christie, D., Egger, S., Sara, S., et al (2024). Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study). BMJ Open, 14(3). [More Information]
• Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L., Tuffaha, H. (2024). The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers. Value in Health. [More Information]

2023

• Kim, L., Bang, S., Sarich, P., Nair-Shalliker, V., Patel, M., Smith, D. (2023). Alcohol consumption and socioeconomic status associated with the risk of kidney cancer in a large Australian cohort study. Annals of Epidemiology, 84, 16-24. [More Information]
• Kohar, A., Cramb, S., Pickles, K., Smith, D., Baade, P. (2023). Changes in prostate specific antigen (PSA) “screening” patterns by geographic region and socio-economic status in Australia: Analysis of medicare data in 50–69 year old men. Cancer Epidemiology, 83. [More Information]
• Egger, S., Smith, D., Patel, M., Kimlin, M., Armstrong, B., Nair-Shalliker, V. (2023). Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study. British Journal of Cancer, 128(1), 71-79. [More Information]
• Cameron, J., Chandrasiri, U., Millar, J., Aitken, J., Cramb, S., Dunn, J., Frydenberg, M., Rashid, P., Mengersen, K., Chambers, S., Smith, D., et al (2023). Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia. PloS One, 18(2024-11-11 00:00:00). [More Information]
• Tuffaha, H., Edmunds, K., Fairbairn, D., Roberts, M., Chambers, S., Smith, D., Horvath, L., Arora, S., Scuffham, P. (2023). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases. [More Information]
• Yu, X., Weber, M., Smith, D., Velentzis, L., Kliewer, E., David, M., Feletto, E. (2023). Incidence profile of four major cancers among migrants in Australia, 2005–2014. Journal of Cancer Research and Clinical Oncology. [More Information]
• Chiam, K., Crowe, J., Grogan, P., Vaneckova, P., Kohar, A., Mazariego, C., Nair-Shalliker, V., Smith, D. (2023). Making informed decisions about prostate cancer testing Locally tailored factsheets on the burden of prostate cancer in Australia. Australian Journal of General Practice, 52(3), 102-105. [More Information]
• Kohar, A., Cramb, S., Pickles, K., Smith, D., Baade, P. (2023). Spatial patterns of prostate-specific antigen testing in asymptomatic men across Australia: a population-based cohort study, 2017–2018. Public Health, 217, 173-180. [More Information]

2022

• Luo, Q., Yu, X., Kahn, C., Egger, S., Patel, M., Grogan, P., Caruana, M., Canfell, K., Smith, D., O'Connell, D. (2022). Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia. Cancer Epidemiology, 78, 102159. [More Information]
• Nair-Shalliker, V., Bang, S., Egger, S., Yu, X., Chiam, K., Steinberg, J., Patel, M., Banks, E., O'Connell, D., Armstrong, B., Smith, D. (2022). Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study. British Journal of Cancer, 127(4), 735-746. [More Information]
• Egger, S., Smith, D., Nair-Shalliker, V. (2022). Methodological considerations in D-health cancer mortality results. The Lancet Diabetes and Endocrinology, 10(5), 307. [More Information]
• Gallagher, B., Coughlin, E., Nair-Shalliker, V., McCaffery, K., Smith, D. (2022). Socioeconomic differences in prostate cancer treatment: A systematic review and meta-analysis. Cancer Epidemiology, 79, 102164. [More Information]

2021

• Mazariego, C., Laidsaar-Powell, R., Smith, D., Juraskova, I. (2021). Avoiding the 'survivorship abyss': Qualitative insights from 15-year prostate cancer survivors. Psycho-Oncology, 30(10), 1745-1755. [More Information]
• Chiam, K., Bang, S., Patel, M., Nair-Shalliker, V., O'Connell, D., Smith, D. (2021). Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men. Cancer Epidemiology Biomarkers and Prevention, 30(9), 1735-1743. [More Information]
• Scheinberg, T., Goodwin, A., Ip, E., Linton, A., Mak, B., Smith, D., Stockler, M., Strach, M., Tran, B., Young, A., Zhang, A., Mahon, K., Horvath, L. (2021). Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate Cancer. JCO Oncology Practice, 17(2), e204-e216. [More Information]
• Nair-Shalliker, V., Smith, D., Gebski, V., Patel, M., Frydenberg, M., Yaxley, J., Gardiner, R., Espinoza, D., Kimlin, M., Fenech, M., Woo, H., Rasiah, K., Symons, J., et al (2021). High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial. BMJ Open, 11(3), e044055. [More Information]
• Rutherford, C., Patel, M., Tait, M., Smith, D., Costa, D., Sengupta, S., King, M. (2021). Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review. Quality of Life Research, 30(2), 345-366. [More Information]
• Yap, M., O'Connell, D., Goldsbury, D., Weber, M., Smith, D., Barton, M. (2021). Patterns of care for men with prostate cancer: the 45 and Up Study. Medical Journal of Australia, 214(6), 271-278. [More Information]
• O’Callaghan, M., Papa, N., Pase, M., Frydenberg, M., Mark, S., Moretti, K., Maqsood, S., Smith, D., Walker, T., White, C., et al (2021). Patterns of care for prostate cancer treatment and improving outcomes – are national registries the answer? BJU International, 128(S1), 6-8. [More Information]
• Chiam, K., Carle, C., Hughes, S., Kench, J., Woo, H., Lord, S., Smith, D. (2021). Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios. Prostate Cancer and Prostatic Diseases, 24(3), 662-673. [More Information]

2020

• Mazariego, C., Egger, S., King, M., Juraskova, I., Woo, H., Berry, M., Armstrong, B., Smith, D. (2020). Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. BMJ, 371, 1-11. [More Information]
• Mazariego, C., Juraskova, I., Campbell, R., Smith, D. (2020). Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care and Outcomes Study. Supportive Care in Cancer, 28(11), 5511-5520. [More Information]
• Nair-Shalliker, V., Bang, A., Egger, S., Clements, M., Gardiner, R., Kricker, A., Seibel, M., Chambers, S., Kimlin, M., Armstrong, B., Smith, D. (2020). Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Scientific Reports, 10(1), 1-11. [More Information]
• Egger, S., Smith, D., Brown, B., Kneebone, A., Dominello, A., Brooks, A., Young, J., Xhilaga, M., Haines, M., O'Connell, D. (2020). Urologists' referral and radiation oncologists' treatment patterns regarding high-risk prostate cancer patients receiving radiotherapy within 6 months after radical prostatectomy: A prospective cohort analysis. Journal of Medical Imaging and Radiation Oncology, 64(1), 134-143. [More Information]

2019

• Lew, J., Feletto, E., Wade, S., Caruana, M., Kang, Y., Nickson, C., Simms, K., Procopio, P., Taylor, N., Worthington, J., Smith, D., Canfell, K. (2019). Benefits, harms and cost-effectiveness of cancer screening in Australia: An overview of modelling estimates. Public Health Research and Practice, 29(2), 1-11. [More Information]
• Hughes, S., Egger, S., Carle, C., Smith, D., Chambers, S., Kahn, C., Caperchione, C., Moxey, A., O'Connell, D. (2019). Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors. PloS One, 14(10), 1-17. [More Information]
• Calopedos, R., Bang, A., Baade, P., Yu, X., Ruthven, S., Patel, M., Smith, D. (2019). Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: An Australian population-based study. Australian Journal of Rural Health, 27(3), 216-223. [More Information]
• Mercieca-Bebber, R., Costa, D., Norman, R., Janda, M., Smith, D., Grimson, P., Gamper, E., King, M. (2019). The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values. Medical Journal of Australia, 210(11), 499-506. [More Information]

2018

• Ettridge, K., Bowden, J., Chambers, S., Smith, D., Murphy, M., Evans, S., Roder, D., Miller, C. (2018). "Prostate cancer is far more hidden..": Perceptions of stigma,social isolation and help-seeking among men with prostate cancer. European Journal of Cancer Care, 27(2), 1-12. [More Information]
• Brown, B., Young, J., Smith, D., Kneebone, A., Brooks, A., Egger, S., Xhilaga, M., Dominello, A., O'Connell, D., Haines, M. (2018). A multidisciplinary team-oriented intervention to increase guideline recommended care for high-risk prostate cancer: A stepped-wedge cluster randomised implementation trial. Implementation Science, 13(1), 43. [More Information]
• Cole-Clark, D., Nair-Shalliker, V., Bang, A., Rasiah, K., Chalasani, V., Smith, D. (2018). An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Scientific Reports, 8(1), 1-7. [More Information]
• Rutherford, C., Patel, M., Tait, M., Smith, D., Costa, D., King, M. (2018). Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review. Supportive Care in Cancer, 26(4), 1061-1076. [More Information]
• Nair-Shalliker, V., Eager, S., Chrzanowska, A., Mason, R., Waite, L., Le Couteur, D., Seibel, M., Handelsman, D., Cumming, R., Smith, D., Armstrong, B. (2018). Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels. PloS One, 13(3), 1-12. [More Information]
• Nag, N., Millar, J., Davis, I., Costello, S., Duthie, J., Mark, S., Delprado, W., Smith, D., Pryor, D., Brooks, A., et al (2018). Development of Indicators to Assess Quality of Care for Prostate Cancer. European Urology Focus, 4(1), 57-63. [More Information]
• Nair-Shalliker, V., Bang, A., Weber, M., Goldsbury, D., Caruana, M., Emery, J., Banks, E., Canfell, K., O'Connell, D., Smith, D. (2018). Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study. Scientific Reports, 8(1), 4261. [More Information]
• Egger, S., Hughes, S., Smith, D., Chambers, S., Kahn, C., Moxey, A., O'Connell, D. (2018). Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors. PloS One, 13(3), 1-13. [More Information]
• Smith, D., Calopedos, R., Bang, A., Yu, X., Egger, S., Chambers, S., O’Connell, D. (2018). Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data. PloS One, 13(6), 1-12. [More Information]
• Egger, S., Calopedos, R., O’Connell, D., Chambers, S., Woo, H., Smith, D. (2018). Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer. European Urology, 73(6), 859-867. [More Information]

2017

• Rutherford, C., Costa, D., King, M., Smith, D., Patel, M. (2017). A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer. Supportive Care in Cancer, 25(10), 3095-3102. [More Information]
• Luo, Q., Yu, X., Smith, D., Goldsbury, D., Cooke-Yarborough, C., Patel, M., O'Connell, D. (2017). Cancer-related hospitalisations and 'unknown' stage prostate cancer: A population-based record linkage study. BMJ Open, 7(1), 1-10. [More Information]
• Patel, M., Beattie, K., Bang, A., Gurney, H., Smith, D. (2017). Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival. Cancer Medicine, 6(10), 2188-2193. [More Information]
• Gordon, L., Walker, S., Mervin, M., Lowe, A., Smith, D., Gardiner, R., Chambers, S. (2017). Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. European Journal of Cancer Care, 26(1), e12392. [More Information]
• Cronin, P., Kirkbride, B., Bang, A., Parkinson, B., Smith, D., Haywood, P. (2017). Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia. Asia-Pacific Journal of Clinical Oncology, 13(3), 160-171. [More Information]
• Chambers, S., Occhipinti, S., Foley, E., Clutton, S., Legg, M., Berry, M., Stockler, M., Frydenberg, M., Gardiner, R., Lepore, S., Smith, D., et al (2017). Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology, 35(3), 291-297. [More Information]
• Chambers, S., Hyde, M., Smith, D., Hughes, S., Yuill, S., Egger, S., O'Connell, D., Stein, K., Frydenberg, M., Wittert, G., et al (2017). New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications. Psycho-Oncology, 26(7), 873-913. [More Information]
• Yu, X., Luo, Q., Smith, D., Clements, M., Patel, M., O'Connell, D. (2017). Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study. PloS One, 12(2), 1-12. [More Information]
• Patel, M., Strahan, S., Bang, A., Vass, J., Smith, D. (2017). Predictors of surgical approach for the management of renal cell carcinoma: a population-based study from New South Wales. ANZ Journal of Surgery, 87(11), E193-E198. [More Information]
• Rutherford, C., King, M., Smith, D., Costa, D., Tait, M., Patel, M. (2017). Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol. Journal of Medical Internet Research, 6(11), 1-12. [More Information]
• Luo, Q., Egger, S., Yu, X., Smith, D., O'Connell, D. (2017). Validity of using multiple imputation for "unknown" stage at diagnosis in populationbased cancer registry data. PloS One, 12(6), 1-16. [More Information]

2016

• Patel, M., Yuminaga, Y., Bang, A., Lawrentschuk, N., Skyring, T., Smith, D. (2016). Volume-outcome relationship in penile cancer treatment: a population based patterns of care and outcomes study from Australia. BJU International, 118(Suppl 3), 35-42. [More Information]

2015

• Chambers, S., Scuffham, P., Baade, P., Lowe, A., Dunn, J., Galvão, D., Gordon, L., Smith, D., Sandoe, D., Wootten, A., et al (2015). Advancing prostate cancer survivorship research in Australia. Cancer Forum, 39(3), 204-209. [More Information]

2014

• Cheluvappa, R., Smith, D., Cerimagic, S., Patel, M. (2014). A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia. International Urology and Nephrology, 46(7), 1351-1360. [More Information]

2013

• Latz, I., Weber, M., Korda, R., Smith, D., Clements, M., Patel, M., Dwyer, T., Tikellis, G., Banks, E. (2013). Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study. World Journal of Urology, 31(3), 673-682. [More Information]
• Weber, M., Smith, D., O'Connell, D., Patel, M., De Souza, P., Sitas, F., Banks, E. (2013). Risk factors for erectile dysfunction in a cohort of 108 477 Australian men. Medical Journal of Australia, 199(2), 107-111. [More Information]
• Weber, M., Cunich, M., Smith, D., Salkeld, G., Sitas, F., O'Connell, D. (2013). Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. BMC Public Health, 13(429), 1-13. [More Information]
• Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., O'Connell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.

2012

• Litchfield, M., Cumming, R., Smith, D., Naganathan, V., Le Couteur, D., Waite, L., Blyth, F., Handelsman, D. (2012). Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study. Medical Journal of Australia, 196(6), 395-398. [More Information]
• Nair-Shalliker, V., Smith, D., Egger, S., Hughes, A., Kaldor, J., Clements, M., Kricker, A., Armstrong, B. (2012). Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study. International Journal of Cancer, 131(5), E726-E732. [More Information]
• King, M., Viney, R., Smith, D., Hossain, I., Street, D., Savage, E., Fowler, S., Berry, M., Stockler, M., Cozzi, P., Armstrong, B., et al (2012). Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer, 106(4), 638-645. [More Information]

2011

• Yu, X., Smith, D., Clements, M., Patel, M., McHugh, B., O'Connell, D. (2011). Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study. BMJ Open, 1, e000104 - 1-e000104 - 5. [More Information]

2009

• Weber, M., Banks, E., Smith, D., O'Connell, D., Sitas, F. (2009). Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health, 9, 144. [More Information]
• Smith, D., King, M., Egger, S., Berry, M., Stricker, P., Cozzi, P., Ward, J., O'Connell, D., Armstrong, B. (2009). Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ: British Medical Journal, 339, b4817-1-b4817-12. [More Information]

2008

• Hayen, A., Smith, D., Patel, M., O'Connell, D. (2008). Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation. Australian and New Zealand Journal of Public Health, 32(5), 417-420. [More Information]

2007

• Smith, D., Supramaniam, R., King, M., Ward, J., Berry, M., Armstrong, B. (2007). Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. Journal of Clinical Oncology, 25(18), 2560-2566. [More Information]

2004

• Yu, X., Smith, D., O’Connell, D., Gibberd, R., Dickman, P., Armstrong, B. (2004). Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes and Control, 15(6), 611-618. [More Information]
• Heathcote (nee Jong), K., Heathcote (nee Jong), K., Smith, D., Smith, D., Yu, X., Yu, X., O'Connell, D., O'Connell, D., Goldstein, D., Goldstein, D., Armstrong, B., Armstrong, B. (2004). Remoteness Of Residence And Survival From Cancer In New South Wales. Medical Journal of Australia, 180(12), 618-622. [More Information]

2003

• Smith, D., Jones, S., Serpell, L., Sunde, M., Radford, S. (2003). A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. Journal of Molecular Biology, 330(5), 943-954. [More Information]